CDKL5 and epilepsy: Mosaicism is increasingly appreciated as a factor in the occurrence and variability of genetic disease, with mosaic pathogenic variants found in up to 8% of affected probands with other X-linked neurodevelopmental disorders such as CDKL5 and PCDH19 epilepsy [116].